Target intelligence / Profile preview

CXXC finger protein 1 (CXXC1 (CFP1))

Target
CXXC1 (CFP1)
Molecular classification
Transcription factor, Chromatin modifier, Histone modification enzyme cofactor (SETD1/COMPASS complex component), DNA-binding protein
01

Overview

CXXC finger protein 1 (CXXC1/CFP1) is a DNA-binding protein featuring a CXXC-type zinc finger domain and a PHD finger domain. CXXC1 binds specifically to unmethylated CpG motifs—especially CpG islands within active promoters—via its CXXC domain, and functions as a targeting subunit for the SETD1/COMPASS histone H3K4 methyltransferase complex[2][4][6]. Through this activity, CXXC1 ensures proper chromatin state, regulating gene expression, and maintaining the epigenetic landscape necessary for cell differentiation and development[1][2][4][6]. In immune cells, CXXC1 is a critical cofactor for FOXP3, orchestrating the regulatory T cell transcriptional program; its loss disrupts immune homeostasis and can induce severe autoimmune disease in model organisms[5]. Structure-function studies reveal CXXC1 contains redundant domains crucial for cytosine methylation and histone modification, and knockout models display broad defects across growth, differentiation, and DNA repair pathways[1][3][4]. CXXC1 has not been identified as a direct drug target, but its role in epigenetic regulation makes it a potential locus for future therapeutic development, particularly in oncology, immunology, and developmental disorder research.

Other names
CFP1CGBPPCCX1PHF18HsT2645SPP1ZCGPC1CpG-binding proteinDNA-binding protein with PHD finger and CXXC domainPHD finger and CXXC domain-containing protein 12410002I16Rik5830420C16Rik
02

Mechanism of action

Not directly targeted by known drugs; theoretical mechanism would involve: - Inhibition of CpG binding - Modulation of SETD1/COMPASS complex activity - Alteration of histone/K4 methylation

03

Biological functions

Regulation of chromatin structureTranscriptional activation via binding unmethylated CpG motifsTargeting histone H3K4 methyltransferase complex (SETD1/COMPASS) to CpG islandsMaintenance of epigenetic markers (e.g., H3K4me3)Cell differentiationRegulation of DNA methylationMeiotic recombination (via interaction with PRDM9 and IHO1 in gametogenesis)
04

Disease associations

Cancer (H3K4 methylation/epigenetic dysregulation)Autoimmunity (e.g., regulatory T cell dysfunction leads to early-onset inflammation/autoimmune disease in animal models)Developmental disorders (knockout models show severe developmental defects)
05

Safety considerations

Essential for development—complete deletion leads to loss of cell function and embryo lethalityDysregulation linked to autoimmunity and inflammatory disease
06

Interacting drugs

No direct drug interactions are reported in the cited literature. However, CXXC1/SETD1-associated complexes may be indirectly targeted by epigenetic drugs (e.g., histone methyltransferase inhibitors); this is extrapolated from related literature but not explicitly detailed in any citation.
07

Biomarkers

H3K4me3 levels and chromatin methylation status may serve as indirect biomarkers of CXXC1 activity, especially in developmental biology, oncology, and immune modulation studies

Beyond the preview

Go deeper on CXXC finger protein 1 (CXXC1 (CFP1)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CXXC finger protein 1 (CXXC1 (CFP1)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call